Given how speculative the possible Cigna (CI)/Humana (HUM) merger is at this stage and antitrust concerns, we aren’t changing our fair value estimates on either firm, notes Morningstar’s Julie Utterback. She evaluates the potential CI/HUM merger, as well as the regulatory hurdles for the potential merger. She talks about how antitrust regulators have recently blocked two horizontal acquisitions in this industry. Tune in to find out more about the stock market today.